{
    "project_id": "171078",
    "broad_study_type": "other",
    "narrow_study_type": "mechanistic_study",
    "trial_phase": "N/A",
    "observational_timeframe": "N/A",
    "justification": "We are studying how hormones produced by the pituitary and adrenal glands control the sensitivity of an organism to the toxic effects of aromatic hydrocarbons and how these chemicals interfere with the normal functions of pituitary hormones.",
    "data_type": "canadian",
    "ipd_used": "individual",
    "novelty_statement": "In this way, we will have a clearer appreciation of why exposure to such chemicals can be detrimental and how we can prevent the adverse effects of chemical exposure.",
    "replication_study": "no",
    "target_population_size": "N/A",
    "age_range": "unclear",
    "gender_focus": "unclear",
    "vulnerable_populations": "no",
    "rare_disease": "no",
    "population_description": "N/A",
    "intervention_category": "N/A",
    "intervention_name": "N/A",
    "control_type": "experimental_control",
    "dose_response": "unclear",
    "combination_therapy": "no",
    "personalized_medicine": "no",
    "primary_outcome": "endocrine disruption by polycyclic aromatic hydrocarbons",
    "primary_outcome_type": "biomarker",
    "safety_focus": "no",
    "quality_of_life": "no",
    "biomarker_endpoints": "yes",
    "time_to_event": "no",
    "composite_endpoint": "no",
    "ai_machine_learning": "no",
    "digital_health": "no",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "no",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "no",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "no",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "no",
    "real_world_evidence": "no",
    "industry_partnership": "no",
    "patient_engagement": "no",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "no",
    "ethics_focus": "no",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "endocrinology",
    "disease_stage": "unclear",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "yes",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "no",
    "cohort_establishment": "no",
    "platform_trial": "no",
    "study_duration": "long_term",
    "multicenter": "no",
    "healthcare_setting": "laboratory",
    "disease_area": "cancer, developmental and reproductive disorders",
    "methodology_innovation": "investigating the mechanisms by which aromatic hydrocarbons interfere with the endocrine system, with a focus on pituitary and adrenal hormones and cytochrome P450 enzymes",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 